Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD-Reference-Cited by-同舟云学术

Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD

Published:2020 Issue: Volume:31 Page:101200
ISSN:2213-0071
Container-title:Respiratory Medicine Case Reports
language:en
Short-container-title:Respiratory Medicine Case Reports

Author:

Inoue Hideki,Jinno Megumi,Ohta Shin,Kishino Yasunari,Kawahara Tomoko,Mikuni Hatsuko,Sato Haruna,Yamamoto Mayumi,Sato Yoko,Onitsuka Chisato,Goto Yuiko,Ikeda Hitoshi,Sato Hiroki,Uno Tomoki,Uchida Yoshitaka,Kimura Tomoyuki,Miyata Yoshito,Hirai Kuniaki,Homma Tetsuya,Watanabe Yoshio,Kusumoto Sojiro,Suzuki Shintaro,Tokimatsu Issei,Tanaka Akihiko,Sagara Hironori

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference13 articles.

1. The SARS-CoV-2 outbreak: what we know;Wu;Int. J. Infect. Dis.,2020

2. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments;Ledford;Nature,2020

3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res.,2020

4. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses;Delang;Antivir. Res.,2018

5. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China;Wu;J. Am. Med. Assoc.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticosteroids: A boon or bane for COVID-19 patients?;Steroids;2022-12

2. Risk/Benefit Profiles of Currently Approved Oral Antivirals for Treatment of COVID-19: Similarities and Differences;COVID;2022-07-28

3. Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline;Pharmaceutics;2022-01-27

4. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses;Virology;2022-01

5. Mechanosynthesis, Characterization, and Physicochemical Property Investigation of a Favipiravir Cocrystal with Theophylline and GRAS Coformers;Crystal Growth & Design;2021-07-22